Literature DB >> 18806702

Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.

Michael Camilleri1.   

Abstract

To review the rationale and current evidence for the efficacy of probiotics in the treatment of irritable bowel syndrome (IBS), the following specific questions are addressed from a review of the published literature: Are bacterial flora altered in IBS? Is infection a significant risk factor for IBS? How prominent is the inflammation in IBS? Do probiotics change bacterial flora? Do probiotics adhere to mucosa? What are the potential mechanisms of action of probiotics in IBS: immune function, motor, secretory, sensory, and fermentation? What is the efficacy of probiotics in IBS?

Entities:  

Mesh:

Year:  2008        PMID: 18806702     DOI: 10.1097/MCG.0b013e3181574393

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

Review 1.  Post-infectious irritable bowel syndrome.

Authors:  Marroon Thabane; John K Marshall
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

2.  A feasibility study of probiotics pretreatment as a bowel preparation for colonoscopy in constipated patients.

Authors:  Hyuk Lee; Young-Ho Kim; Jeong Hwan Kim; Dong Kyung Chang; Jin Yong Kim; Hee Jung Son; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

Review 3.  Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.

Authors:  Uday C Ghoshal; Deepakshi Srivastava
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

4.  Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35.

Authors:  Bertrand Evrard; Sophie Coudeyras; Annie Dosgilbert; Nicolas Charbonnel; Josette Alamé; Arlette Tridon; Christiane Forestier
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

5.  Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial.

Authors:  Seok-Jae Ko; Bongha Ryu; Jinsung Kim; Beom-Gi Hong; Inkwon Yeo; Beom-Joon Lee; Jin-Moo Lee; Jae-Woo Park
Journal:  Trials       Date:  2011-10-06       Impact factor: 2.279

6.  Effect of breadmaking process on in vitro gut microbiota parameters in irritable bowel syndrome.

Authors:  Adele Costabile; Sara Santarelli; Sandrine P Claus; Jeremy Sanderson; Barry N Hudspith; Jonathan Brostoff; Jane L Ward; Alison Lovegrove; Peter R Shewry; Hannah E Jones; Andrew M Whitley; Glenn R Gibson
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.